ITRMF · Iterum Therapeutics plc · Shareholders & Ownership
Substantial doubt about the company's ability to continue as a going concern.
“This condition raises substantial doubt about the Company's ability to continue as a going concern for one year from the date these condensed consolidated financial statements are issued.”View the 10-Q filed Nov 14, 2025
Every disclosed holder of ITRMF in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.
Who Owns ITRMF
13F quarter Jun 30, 2026| Holder group | Shares | % Out |
|---|---|---|
| Institutional (13F) | 10,861 | 0.02% |
| Insiders (Forms 3, 4, 5) | 241,001 | 0.54% |
| 13D/G-only blocks | 1,445,158 | 3.24% |
| Remaining | 42,959,886 | 96.20% |
| Registered funds (N-PORT, not summed) | 0 | 0.00% |
Shares outstanding: 44,656,906, the issuer's latest cover-page count restated onto today's split basis.
13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.
Holders of ITRMF
| # | Holder | Shares | As of | Notes |
|---|---|---|---|---|
| 1 |
ARMISTICE CAPITAL, LLC
13G
CIK 1601086 · Registered investment adviser · Dec 31, 2024
Rule 13d-1(b), qualified institution
|
1,445,158 | ||
| 2 |
|
241,001 | ||
| 3 |
BARCLAYS PLC
13F
CIK 312069 · Bank · Jun 30, 2026
|
10,795 | ||
| 4 |
Cypress Capital Management LLC (WY)
13F
CIK 1633896 · Registered investment adviser · Jun 30, 2026
|
66 |
Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.